Skip to main content
FinSpry Logo
FinSpry
KRYS logo
KRYS
(NASDAQ)
Krystal Biotech, Inc.
$327.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Krystal Biotech (KRYS) Stock Price & Financial Analysis

Krystal Biotech Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$326.08 - $336.49
52-Week High$382.54
52-Week Low$130.50
Open$333.25
Volume4.64M
Average Volume (3M)535.87K
Market Cap9.99B
Shares Outstanding30.51M
P/E Ratio (TTM)44.40
Forward P/E24.06
Price to Sales (P/S)23.94
Price to Book (P/B)7.83
EV/EBITDA53.11
Revenue (TTM)417.30M
Net Income (TTM)225.03M
Free Cash Flow (TTM)237.38M
EPS (TTM)$7.50
Profit Margin53.92%
Operating Margin42.85%
Return on Equity (ROE)17.63%
Debt to Equity0.01
50-Day MA$331.52
200-Day MA$266.88
52-Week Change113.70%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Krystal Biotech

What is the current stock price for KRYS?

As of the latest trading session, KRYS stock trades at $327.50. The 52-week range is $130.50–$382.54, with a day range of $326.08–$336.49.

What is the P/E ratio for KRYS?

Krystal Biotech's trailing P/E ratio is 44.4, meaning investors pay $44.4 for every $1 of annual earnings. The forward P/E is 24.1, reflecting analyst expectations for future earnings. Krystal Biotech operates in the Healthcare sector.

Does KRYS pay dividends?

Krystal Biotech does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KRYS?

Based on 9 analysts, the consensus for KRYS is Buy.

What is the market cap of KRYS?

Krystal Biotech's market capitalization is $9.99B, classifying it as a mid-cap company. Krystal Biotech operates in the Healthcare sector within the Biotechnology industry.